Evidence map›Paper›PMID 9666018›Full record

ArticleJournal of clinical microbiology1998

Identification of a rough strain of Escherichia coli O157:H7 that produces no detectable O157 antigen.

P Feng, R C Sandlin, C H Park, R A Wilson, M Nishibuchi

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical microbiology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 2 countries.

P FengDivision of Microbiological Studies, Food and Drug Administration, Washington, D.C. 20204, USA. pxf@fdacf.ssw.dhhs.gov
R C Sandlin
C H Park
R A Wilson
M Nishibuchi
Inova Fairfax Hospital · USKyoto University · JPPennsylvania State University · USUniformed Services University of the Health Sciences · USUnited States Food and Drug Administration · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MA6, an O157:H7-like strain, did not react with most anti-O157 kits examined; however, it had the rfbE gene that is essential for O157 expression and carried O157:H7 virulence factors. Lipopolysaccharide analysis showed that MA6 is a rough strain that does not produce the O157 antigen, but genetically, it belongs in the O157:H7 clonal group.

Indexed as

AnimalsBacterial Typing TechniquesCarbohydrate EpimerasesCattleEscherichia coli O157LipopolysaccharidesMeatO AntigensPolymerase Chain ReactionSerotypingTransaminasesCarbohydrate EpimerasesLipopolysaccharidesO Antigensperosamine synthetaseTransaminases

Identifiers

PMID9666018
PMCPMC105044
OpenAlexW2108067371

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.